If the patient feels they need to confirm with another successful trial before deciding on permanent placement, I think the carrier would agree this be worth the cost. I am not sure if your state Medicare carrier has an LCD for SCS procedures. Below it does not mention second trials in the NCD I also found some additional info that I thought was informative.
When asked at 24 months:
- 66% patients were satisfied with their
- 93% patients said they would repeat
â€˘ 19/42 (45%) patients experienced 34 SCS-related
- 13/42 patients (31%) required a device-related
- Most occurred in the first year and were
benign, reversible, and not incapacitating.
Patients eligible for lumbar or thoracic dorsal column SCS experience pain relief from a temporary trial of SCS and demonstrate a psychological profile that would be consistent with successful dorsal column stimulation.
U.S. Food and Drug Administration (FDA)
SCS devices are approved for use â€śas an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain and leg painâ€ť (FDA, 2004).
- ICD-10 Trainings
- Comprehensive Courses
- CPC (Certified Professional Coder)
- COC (Certified Outpatient Coder)
- CIC (Certified Inpatient Coder) NEW!
- CRC (Certified Risk Adjustment Coder) NEW!
- CPB (Certified Professional Biller)
- CPMA (Certified Professional Medical Auditor)
- CDEO (Certified Documentation Expert – Outpatient) NEW!
- CPPM (Certified Physician Practice Manager)
- CPCO (Certified Professional Compliance Officer)
- VIEW ALL CERTIFICATIONS
Coding / Billing Solutions
- Audit / Compliance Solutions
Job Experience / Apprentice Removal
News / Discussion
- Other Resources
- Book Store
- Log In / Join